Titrated Versus High and Low Dose Nebulized Morphine to Reduce Pain in Emergency Settings

NCT ID: NCT02200185

Last Updated: 2014-12-02

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

300 participants

Study Classification

INTERVENTIONAL

Study Start Date

2012-04-30

Study Completion Date

2014-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The investigators test a different technique using morphine to improve pain relief in patient visiting the emergency department with acute trauma pain, for this we are comparing three different methods of morphine administration:

* intravenous titrated morphine
* low dose nebulized morphine and
* high dose nebulized morphine

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Trauma patients are frequent in emergency department settings, and often require urgent care.

taking care of this patients consists on taking care of their pain and then the specific treatment of their traumatic lesions.

actually, the most used medicine and most efficient one in treating pain is morphine, it's mechanism of action is by acting on receptors located on neuronal cell membranes and inhibit neurotransmitter release.

The most applied administration root of morphine is by intravenous (IV) titration or IV continuous perfusion, but until now, there is no clear recommendation concerning the superiority of this root over other administration techniques such as nebulization.

In this study we aimed to investigate the efficiency, the feasibility and the tolerance of three morphine administration roots in patients with acute traumatic pain and to clarify the most adequate one to apply in emergency department settings.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Post-Traumatic Headache Acute Pain

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Caregivers

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

IV titrated morphine

patient will receive 2 mg morphine each 5 min, associated to continuous nebulisation of saline serum (placebo).

Morphine administration is stopped when VAS becomes under 50% and treatment failure is defined as VAS \> 50%, 30 minutes after the beginning of the protocol.

Group Type PLACEBO_COMPARATOR

IV titrated morphine

Intervention Type DRUG

Intravenous morphine : 2 mg every 5 minutes by IV root and nebulized placebo:

* SS nebulised : 5 ml SS nebulised over 10 minutes and repeated 3 times

Low dose nebulised morphine

patient will receive 10 mg of morphine prepared with 4 ml saline serum (SS) and nebulised with 6 l/min flow during 10 minutes.

Nebulisation will be repeated 3 times, in addition, patients receive 2 ml IV SS every 5 minutes as placebo

Group Type EXPERIMENTAL

Low dose nebulised morphine

Intervention Type DRUG

10 mg morphine in 4 ml Serum Saline(SS) nebulised over 10 minutes and repeated 3 times, and SS IV placebo : 2 ml by IV root every 5 minutes

High dose nebulised morphine

patient will receive 20 mg of morphine prepared with 3 ml saline serum (SS) and nebulised with 6 l/min flow during 10 minutes.

Nebulisation will be repeated 3 times, in addition, patients receive 2 ml IV SS every 5 minutes as placebo.

Group Type EXPERIMENTAL

High dose nebulised morphine

Intervention Type DRUG

20 mg morphine in 3 ml serum saline (SS) nebulised over 10 minutes and repeated 3 times, and SS IV placebo : 2 ml by IV root every 5 minutes

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

IV titrated morphine

Intravenous morphine : 2 mg every 5 minutes by IV root and nebulized placebo:

* SS nebulised : 5 ml SS nebulised over 10 minutes and repeated 3 times

Intervention Type DRUG

Low dose nebulised morphine

10 mg morphine in 4 ml Serum Saline(SS) nebulised over 10 minutes and repeated 3 times, and SS IV placebo : 2 ml by IV root every 5 minutes

Intervention Type DRUG

High dose nebulised morphine

20 mg morphine in 3 ml serum saline (SS) nebulised over 10 minutes and repeated 3 times, and SS IV placebo : 2 ml by IV root every 5 minutes

Intervention Type DRUG

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

IV morphine group Neb10 Neb20

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* patients older than 8 years and less than 50 years
* patients who consult emergency department for sever pain after an immediately trauma

Exclusion Criteria

* Glasgow coma scale \<14
* inability to cooperate
* hypotension with systolic blood pressure\< 90mmhg
* bradypnea\<12cpm
* SAO2\<90%
* polytrauma
* nasal trauma
* rhinitis
* nasal obstruction
* allergy to opioids
Minimum Eligible Age

8 Years

Maximum Eligible Age

50 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Monastir

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Nouira

Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Nouira Semir, Professor

Role: PRINCIPAL_INVESTIGATOR

University of Monastir

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Emergency Department

Monastir, Monastir Governorate, Tunisia

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Tunisia

References

Explore related publications, articles, or registry entries linked to this study.

Grissa MH, Boubaker H, Zorgati A, Beltaief K, Zhani W, Msolli MA, Bzeouich N, Bouida W, Boukef R, Nouira S. Efficacy and safety of nebulized morphine given at 2 different doses compared to IV titrated morphine in trauma pain. Am J Emerg Med. 2015 Nov;33(11):1557-61. doi: 10.1016/j.ajem.2015.06.014. Epub 2015 Jun 14.

Reference Type DERIVED
PMID: 26143313 (View on PubMed)

Related Links

Access external resources that provide additional context or updates about the study.

http://www.urgencemonastir.com

official department site

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

TIMORNEB

Identifier Type: -

Identifier Source: org_study_id